Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05974488

The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE

The purpose of this study is to investigate the effect of using the McMurray Enhanced Airway (MEA) which is a flexible extended-length distal pharyngeal airway on improving oxygen delivery compared to standard nasal cannula.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jackson Memorial Hospital

Miami, Florida, 33136, United States

Location status: Recruiting

Location contact

Fouad G Souki, MD

CONTACT

[email protected]

3055857435

Fouad G Souki, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > or = 18 years old
  • Patients willing to participate and provide an informed consent
  • Patients scheduled to undergo an elective TEE procedure.

Exclusion criteria

  • Patients with history of uncontrolled gastroesophageal reflux disease
  • Patients with anatomical airway obstruction
  • Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements

Treatment and study plan

McMurray Enhanced Airway

Device

The MEA is non-sterile. It can be used in inpatient or outpatient surgery, in hospital or clinic settings, or in an emergency setting. The MEA has five parts: an optional 15 mm connector, flange (color-coded for size), elongated cushioned bite block, flexible cannula, and distal tip, and a channel to allow for passage of air and a suction catheter. The MEA is designed to open and maintain a patient's upper airway. Oxygen will be delivered through the breathing circuit with the following parameters: 40% oxygen at 6 liters/min flow throughout the procedure time. The MEA will be placed in the participant's oropharyngeal airway one time during an in-person visit.

Nasal Cannula

Device

Participants in this group will use the nasal cannula to deliver oxygen as per standard of care one time during the in-person visit.

Primary outcomes

  1. Incidence of hypoxia

    Time frame: during procedure (up to 60 minutes)

    Determine the incidence of hypoxia defined as oxygen saturation by pulse oximetry (SPo2)= 75-89%.

Secondary outcomes

  1. Incidence of subclinical hypoxia

    Time frame: during procedure (up to 60 minutes)

    Determine the incidence of subclinical hypoxia defined as SPo2= 90-95%.

  2. Incidence of severe Hypoxia

    Time frame: during procedure (up to 60 minutes)

    Determine the incidence of severe hypoxia defined as SPo2<75%.

Study contacts

Contact information is provided by the study sponsor or research team.

Fouad G Souki, MD

CONTACT

[email protected]

(305) 5857435

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Registry information

Official study title

The Efficacy of Distal Pharyngeal Airway in Enhancing Oxygenation During Transesophageal Echocardiography (TEE) in Patients Sedated With Propofol

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Aug 3, 2023
Registry last updated
Oct 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.